Year archive

Sandoz Group AG — 2023 filings

All 6 regulatory filings released by Sandoz Group AG (SDZ) in 2023, sourced directly from the official regulator.

6 Filings

2023 Period

2023 filings (6)

Filing	Released	Lang
Sandoz launches Hyrimoz® (adalimumab) high-concentration formulation in Europe, aiming to improve patient care Regulatory Filings	2023-11-21	English
Sandoz inaugurates new antibiotic production plant in Austria and new biosimilar development center in Germany Regulatory Filings	2023-11-10	English
Sandoz successfully issues EUR 2.0 billion inaugural Eurobonds Capital/Financing Update	2023-11-08	English
Sandoz successfully issues CHF 750 million in inaugural bonds Capital/Financing Update	2023-10-26	English
Sandoz reports year-to-date sales for the first nine months of 2023 Earnings Release 9M 2023	2023-10-24	English
Sandoz enters new era as standalone global leader and European champion in generic and biosimilar medicines Regulatory Filings	2023-10-04	English